78 related articles for article (PubMed ID: 2355691)
1. [The treatment, course and prognosis of sarcoidosis cases].
Takada K; Ina Y; Noda M; Morishita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):92-9. PubMed ID: 2355691
[TBL] [Abstract][Full Text] [Related]
2. Adverse effect of chronic tonsillitis on clinical course of sarcoidosis in relation to HLA distribution.
Ikeda T; Hayashi S; Kamikawaji N; Sasazuki T; Shigematsu N
Chest; 1992 Mar; 101(3):758-62. PubMed ID: 1541144
[TBL] [Abstract][Full Text] [Related]
3. The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis.
Takada K; Ina Y; Noda M; Sato T; Yamamoto M; Morishita M
J Clin Epidemiol; 1993 Apr; 46(4):359-66. PubMed ID: 8483000
[TBL] [Abstract][Full Text] [Related]
4. [The role of human leukocyte antigen in susceptibility and clinical manifestations of sarcoidosis].
Xu Z; Zhu X; Zhao Y
Zhonghua Nei Ke Za Zhi; 1996 Nov; 35(11):730-3. PubMed ID: 9592337
[TBL] [Abstract][Full Text] [Related]
5. [Polymorphism of histocompatibility class II antigens coded with the DRB gene in in familial sarcoidosis in Poland].
Goljan A; Puścińska E; Sankowska M; Zieliński J
Pneumonol Alergol Pol; 2000; 68(11-12):533-44. PubMed ID: 11320564
[TBL] [Abstract][Full Text] [Related]
6. [HLA haplotypes associated with IgA nephropathy].
Ito H
Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):273-80. PubMed ID: 8501857
[TBL] [Abstract][Full Text] [Related]
7. HLA serological and class II genotyping in sarcoidosis patients in Japan.
Ishihara M; Ishida T; Inoko H; Ando H; Naruse T; Nose Y; Ohno S
Jpn J Ophthalmol; 1996; 40(1):86-94. PubMed ID: 8739505
[TBL] [Abstract][Full Text] [Related]
8. HLA and sarcoidosis in the Japanese.
Ina Y; Takada K; Yamamoto M; Morishita M; Senda Y; Torii Y
Chest; 1989 Jun; 95(6):1257-61. PubMed ID: 2721261
[TBL] [Abstract][Full Text] [Related]
9. [Association of I and II class HLA antigens with Cushing's syndrome].
Kalinin AP; Zaretskaia IuM; Andrusenko AB; Abramov VIu; Klinova EG; Bogatyrev OP; Donskov SI
Klin Med (Mosk); 1991 Aug; 69(8):93-5. PubMed ID: 1724274
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the treatment and prognosis of 59 patients with sarcoidosis].
Ding K; Xu ZJ; Huang H; Lu WX; Luo WC
Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):52-5. PubMed ID: 17331391
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.
Berlin M; Fogdell-Hahn A; Olerup O; Eklund A; Grunewald J
Am J Respir Crit Care Med; 1997 Nov; 156(5):1601-5. PubMed ID: 9372682
[TBL] [Abstract][Full Text] [Related]
12. [The effect of therapeutic intervention with corticosteroids on outcome and prognosis of sarcoidosis].
Miao JZ; Du DJ; Zeng P
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jan; 26(1):14-7. PubMed ID: 12775262
[TBL] [Abstract][Full Text] [Related]
13. [A probe for evaluating the role of HLA class II antigens coded with the DRB gene in etiopathogenesis of familial sarcoidosis in Poland using the K-nearest neighbor experimental statistical method].
Goljan A; Puścińska E; Sankowska M; Jóźwik A; Zieliński J
Pneumonol Alergol Pol; 2000; 68(11-12):545-56. PubMed ID: 11320565
[TBL] [Abstract][Full Text] [Related]
14. Serum angiotensin converting enzyme in sarcoidosis: clinical significance.
Silverstein E; Friedland J; Lyons HA
Isr J Med Sci; 1977 Oct; 13(10):1001-6. PubMed ID: 201592
[TBL] [Abstract][Full Text] [Related]
15. HLA class II genotyping of sarcoidosis patients in Hokkaido by PCR-RFLP.
Ishihara M; Inoko H; Suzuki K; Ono H; Hiraga Y; Ando H; Naruse T; Ishida T; Ohno S
Jpn J Ophthalmol; 1996; 40(4):540-3. PubMed ID: 9130059
[TBL] [Abstract][Full Text] [Related]
16. [Research trend for pathogenesis of sarcoidosis--streptococcal cell wall component (SCW)].
Shigematsu N; Kido K; Ikeda T; Kamikawaji N; Sasazuki T
Nihon Rinsho; 1994 Jun; 52(6):1498-502. PubMed ID: 8046830
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases.
Bernard C; Maucort-Boulch D; Varron L; Charlier C; Sitbon K; Freymond N; Bouhour D; Hot A; Masquelet AC; Valeyre D; Costedoat-Chalumeau N; Etienne M; Gueit I; Jouneau S; Delaval P; Mouthon L; Pouget J; Serratrice J; Brion JP; Vaylet F; Bremont C; Chennebault JM; Jaffuel S; Broussolle C; Lortholary O; Sève P;
QJM; 2013 Jun; 106(6):523-39. PubMed ID: 23515400
[TBL] [Abstract][Full Text] [Related]
18. The role of human leukocyte antigen in susceptibility and clinical manifestations of sarcoidosis.
Xu Z; Zhao Y; Zhu X; Qiu C; Luo W; Zhu Y
Chin Med J (Engl); 1996 Jul; 109(7):515-8. PubMed ID: 9206096
[TBL] [Abstract][Full Text] [Related]
19. Sarcoidosis in native Saudis.
Khan J; Døssing M; von Sinner WN; Bazarbashi M; Curley W
Sarcoidosis; 1993 Mar; 10(1):50-5. PubMed ID: 8134717
[TBL] [Abstract][Full Text] [Related]
20. Expression of TRAIL, DR4, and DR5 in bladder cancer: correlation with response to adjuvant therapy and implications of prognosis.
Li Y; Jin X; Li J; Jin X; Yu J; Sun X; Chu Y; Xu C; Li X; Wang X; Kakehi Y; Wu X
Urology; 2012 Apr; 79(4):968.e7-15. PubMed ID: 22244504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
